Prospective evaluation of echocardiography and serum biomarkers as predictors of cardiotoxicity in patients with breast cancer treated with anthracyclines, taxanes, with/without trastuzumab

被引：3
|
作者：
Solar Lopez, Jorge
De Las Penas, Ramon
De Avila, Leticia
De Julian, Maria
Amal, Maria
Martinez-De Duenas, Eduardo
Olmos, Santiago
Lopez-Rodriguez, Angela
Munarriz, Javier
Peset, Ana
Cortell, Alejandro
Rodriguez, Candela
Solloso, Angel
机构：
[1] Oncol Serv Hosp Prov Castellon, Castellon de La Plana, Spain
[2] Hosp Prov, Castellon de La Plana, Spain
[3] Oncol Serv, Castellon de La Plana, Spain
[4] Hosp Prov Castellon, Castellon de La Plana, Spain
[5] Serv Cardiol, Castellon de La Plana, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e20686
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20686
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Troponin I and B-type Natriuretic Peptide (BNP) as biomarkers for the prediction of cardiotoxicity in patients with breast cancer treated with adjuvant anthracyclines and trastuzumab
    Pistillucci, G.
    Ciorra, A. A.
    Sciacca, V.
    Raponi, M.
    Rossi, R.
    Veltri, E.
    CLINICA TERAPEUTICA, 2015, 166 (01): : E67 - E71
  • [22] Evaluation of Cardiotoxicity via Speckle-Tracking Echocardiography in Patients Treated with Anthracyclines
    Dogru, Atalay
    Cabuk, Devrim
    Sahin, Tayfun
    Dolasik, Ilhan
    Temiz, Suleyman
    Uygun, Kazim
    ONKOLOGIE, 2013, 36 (12): : 712 - 716
  • [23] Statins to mitigate cardiotoxicity in breast cancer patients treated with anthracyclines and/or trastuzumab: A systematic review and meta-analysis
    Vo, Jacqueline B.
    Abovich, Arielle
    Obasi, Mary
    Gao, Yawen
    Nohria, Anju
    Asnani, Aarti
    Partridge, Ann H.
    CANCER RESEARCH, 2020, 80 (04)
  • [24] Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab (vol 63, pg 809, 2014)
    Ky, B.
    Putt, M.
    Sawaya, H.
    French, B.
    Januzzi, J. L., Jr.
    Sebag, I. A.
    Plana, J. C.
    Cohen, V
    Banchs, J.
    Carver, J. R.
    Wiegers, S. E.
    Martin, R. P.
    Picard, M. H.
    Gerszten, R. E.
    Halpern, E. F.
    Passeri, J.
    Kuter, I
    Scherrer-Crosbie, M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (11) : 1385 - 1385
  • [25] Gemcitabine in metastatic breast cancer patients previously treated with anthracyclines and taxanes. Evaluation of response toxicity
    Lerzo, GL
    Temperley, G
    Rosales, C
    Campos, C
    Lezcano, A
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S74 - S74
  • [26] Body mass index as a prognostic factor in operable breast cancer patients treated with adjuvant anthracyclines with or without taxanes
    El-Sadda, W.
    El-Ibrashi, M.
    Abdel-Halim, I.
    ANNALS OF ONCOLOGY, 2016, 27
  • [27] Heart rate variability-based prediction of early cardiotoxicity in breast-cancer patients treated with anthracyclines and trastuzumab
    Luna-Alcala, Santiago
    Espejel-Guzman, Adrian
    Lerma, Claudia
    Leon, Paula
    Guerra, Enrique C.
    Espinosa Fernandez, Jose Rodrigo
    Martinez-Dominguez, Pavel
    Serrano-Roman, Javier
    Cabello-Ganem, Aldo
    Aparicio-Ortiz, Alexis D.
    Keirns, Candace
    Lerma, Abel
    Santa Ana-Bayona, Maria Jose
    Espinola-Zavaleta, Nilda
    CARDIO-ONCOLOGY, 2024, 10 (01)
  • [28] Heart rate variability-based prediction of early cardiotoxicity in breast-cancer patients treated with anthracyclines and trastuzumab
    Espinola-Zavaleta, N.
    Luna-Alcala, S.
    Espejel-Guzman, A.
    Lerma, C.
    Leon, P.
    Guerra, E. C.
    Espinoza Fernandez, J. R.
    Martinez-Dominguez, P.
    Serrano-Roman, J.
    Cabello-Ganem, A.
    Aparicio-Ortiz, A. D.
    Keirns, C.
    Lerma, A.
    Santa Ana-Bayona, M. J.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [29] Predictors of cardiotoxicity in patients with breast cancer: a prospective study
    Martins, A. M.
    Silva, B. Valente
    Magalhaes, A.
    Menezes, M. Nobre
    Cortez-Dias, N.
    Costa, P.
    Saraiva, M.
    Pinto, F. J.
    Fiuza, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 245 - 245
  • [30] Bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines.
    Schmid, P
    Schippinger, V
    Kiewe, P
    Lange, W
    Preiss, J
    Niederle, N
    Brossart, P
    Freier, W
    Van de Velde, H
    Possinger, K
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S68 - S69
12345